Kmg Fiduciary Partners, LLC Abb Vie Inc. Transaction History

Kmg Fiduciary Partners, LLC

$1.14 Billion
Q3 2024

A detailed history of Kmg Fiduciary Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kmg Fiduciary Partners, LLC holds 80,472 shares of ABBV stock, worth $14.1 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares

80,472

Previous 86,057 6.49%

Holding current value

$14.1 Million

Previous $14.8 Million 7.66%

% of portfolio

1.39%

Previous 1.46%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$163.84 - $199.33 $915,046 - $1.11 Million	-5,585 Reduced 6.49%	80,472 $15.9 Million
Q2 2024 Jul 17, 2024	BUY	$154.79 - $180.76 $269,953 - $315,245	1,744 Added 2.07%	86,057 $14.8 Million
Q1 2024 Apr 10, 2024	SELL	$159.82 - $182.1 $129,134 - $147,136	-808 Reduced 0.95%	84,313 $15.4 Million
Q4 2023 Jan 10, 2024	BUY	$137.6 - $154.97 $120,400 - $135,598	875 Added 1.04%	85,121 $13.2 Million
Q3 2023 Oct 25, 2023	BUY	$133.59 - $154.65 $274,794 - $318,115	2,057 Added 2.5%	84,246 $12.6 Million
Q2 2023 Jul 14, 2023	BUY	$132.51 - $164.9 $1.99 Million - $2.48 Million	15,054 Added 22.42%	82,189 $11.1 Million
Q1 2023 Apr 13, 2023	BUY	$144.61 - $166.54 $271,866 - $313,095	1,880 Added 2.88%	67,135 $10.7 Million
Q4 2022 Jan 12, 2023	BUY	$138.31 - $165.87 $614,926 - $737,458	4,446 Added 7.31%	65,255 $0
Q3 2022 Oct 27, 2022	BUY	$134.21 - $153.93 $1.2 Million - $1.38 Million	8,967 Added 17.3%	60,809 $8.16 Million
Q2 2022 Jul 13, 2022	SELL	$137.62 - $174.96 $216,751 - $275,562	-1,575 Reduced 2.95%	51,842 $7.94 Million
Q1 2022 Apr 19, 2022	BUY	$131.98 - $163.75 $94,497 - $117,245	716 Added 1.36%	53,417 $8.66 Million
Q4 2021 Jan 12, 2022	BUY	$107.43 - $135.93 $958,705 - $1.21 Million	8,924 Added 20.39%	52,701 $7.14 Million
Q3 2021 Oct 12, 2021	BUY	$106.4 - $120.78 $1.83 Million - $2.08 Million	17,180 Added 64.59%	43,777 $4.72 Million
Q2 2021 Jul 20, 2021	BUY	$105.21 - $117.21 $178,015 - $198,319	1,692 Added 6.79%	26,597 $3 Million
Q1 2021 Apr 08, 2021	BUY	$102.3 - $112.62 $391,502 - $430,996	3,827 Added 18.16%	24,905 $2.7 Million
Q4 2020 Jan 13, 2021	BUY	$80.49 - $108.67 $261,512 - $353,068	3,249 Added 18.22%	21,078 $2.25 Million
Q3 2020 Oct 13, 2020	BUY	$85.91 - $100.83 $59,965 - $70,379	698 Added 4.07%	17,829 $1.56 Million
Q2 2020 Jul 22, 2020	SELL	$73.37 - $98.18 $14,307 - $19,145	-195 Reduced 1.13%	17,131 $1.68 Million
Q1 2020 Apr 29, 2020	BUY	$64.5 - $97.79 $287,218 - $435,458	4,453 Added 34.59%	17,326 $1.32 Million
Q4 2019 Jan 29, 2020	BUY	$72.13 - $90.25 $20,773 - $25,992	288 Added 2.29%	12,873 $1.14 Million
Q3 2019 Oct 15, 2019	SELL	$62.98 - $75.72 $393,876 - $473,552	-6,254 Reduced 33.2%	12,585 $953,000
Q2 2019 Jul 26, 2019	BUY	$65.7 - $83.98 $365,226 - $466,844	5,559 Added 41.86%	18,839 $1.37 Million
Q1 2019 Apr 16, 2019	BUY	$77.14 - $90.79 $474,488 - $558,449	6,151 Added 86.28%	13,280 $1.07 Million
Q4 2018 Apr 15, 2019	BUY	$77.85 - $96.01 $554,992 - $684,455	7,129 New	7,129 $657,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kmg Fiduciary Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kmg Fiduciary Partners, LLC with notifications on news.

Account

Kmg Fiduciary Partners, LLC Abb Vie Inc. Transaction History